StockData
YD Bio Ltd logo

YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.73−0.10 (-2.07%)

Close on Nov 17, 2026Market cap $334.83MP/E –Yield –

YD Bio r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $1.60M, up 226.1% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.60M+226.1%
FY2024Dec 31, 2024$491.35K–

More YD Bio figures

See a number that looks wrong?